Fertolet Tablet 5 is used to treat hormone-receptor-positive breast cancer in postmenopausal women. It is a single-ingredient medicine containing letrozole, an aromatase inhibitor.
This medicine treats hormone-receptor-positive early breast cancer after menopause. It is also used as ongoing treatment in women who have already completed tamoxifen therapy. In addition, it manages locally advanced or metastatic hormone-sensitive breast cancer, including after anti-oestrogen therapy.
Before starting this medicine, tell your doctor about any pre-existing medical conditions, allergies, and all other medicines, supplements or herbal products you take. This medicine must not be used during pregnancy; discuss pregnancy, breastfeeding and contraception with your doctor when relevant. Report any persistent or serious side effects to your doctor. Do not stop this medicine unless your doctor advises you to do so.












































































